Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-03-10
1984-05-22
Helfin, Bernard
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424308, 424304, 560 17, 560 23, 560 62, 560 45, 260465D, C07C 69612, C07C 69618, A61K 31235
Patent
active
044501722
ABSTRACT:
Polyhalohydroxyisopropyl phenylalka(e)noic acid esters of alkylaminohydroxypropyloxyphenylalkyl alcohols, such as 2-(4-((2-hydroxy-3-(1-methylethylamino)-phenyl)ethyl 3-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethylethyl))benzene propanoate, are useful as antihypertensive agents. Preferred compounds give vasodilatory activity and reduced tachycardia.
REFERENCES:
patent: 3236894 (1966-02-01), England
patent: 3873600 (1975-03-01), Brandstrom et al.
patent: 3876802 (1975-04-01), Brandstrom et al.
patent: 4199597 (1980-04-01), Neustadt et al.
patent: 4311708 (1982-01-01), Manoury et al.
E. I. Du Pont de Nemours and Company
Helfin Bernard
LandOfFree
Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1478386